{"address1": "No.1, Dongxing Street", "address2": "Shulin District", "city": "New Taipei City", "zip": "23850", "country": "Taiwan", "phone": "886 2 8684 3318", "website": "https://www.ccsb.com.tw", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Chung-Hsin  Huang", "title": "Pres & GM", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kuan-Chieh  Wang", "title": "Mang. of Fin. & Treasury Dept., and Head of Accounting & Corp. Governance", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jun-Jie  Liao", "title": "Mang. of Human Resource Office", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chao-Sheng  Hong", "title": "Chief Auditor", "exercisedValue": 0, "unexercisedValue": 0}], "maxAge": 86400, "priceHint": 2, "previousClose": 94.9, "open": 93.3, "dayLow": 90.2, "dayHigh": 94.0, "regularMarketPreviousClose": 94.9, "regularMarketOpen": 93.3, "regularMarketDayLow": 90.2, "regularMarketDayHigh": 94.0, "dividendRate": 1.3, "dividendYield": 0.0139, "exDividendDate": 1658448000, "payoutRatio": 0.2192, "fiveYearAvgDividendYield": 2.19, "beta": 0.809604, "trailingPE": 15.817876, "forwardPE": 15.402299, "volume": 5248528, "regularMarketVolume": 5248528, "averageVolume": 4009431, "averageVolume10days": 4700476, "averageDailyVolume10Day": 4700476, "bid": 93.7, "ask": 93.8, "bidSize": 0, "askSize": 0, "marketCap": 7275128320, "fiftyTwoWeekLow": 49.4, "fiftyTwoWeekHigh": 102.5, "priceToSalesTrailing12Months": 3.4362934, "fiftyDayAverage": 81.86, "twoHundredDayAverage": 64.4895, "trailingAnnualDividendRate": 1.3, "trailingAnnualDividendYield": 0.013698629, "currency": "TWD", "enterpriseValue": 7531425792, "profitMargins": 0.22004, "sharesOutstanding": 77560000, "heldPercentInsiders": 0.40686, "heldPercentInstitutions": 0.03486, "impliedSharesOutstanding": 0, "bookValue": 41.166, "priceToBook": 2.2785795, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1672444800, "earningsQuarterlyGrowth": -0.237, "netIncomeToCommon": 465864992, "trailingEps": 5.93, "forwardEps": 6.09, "enterpriseToRevenue": 3.557, "enterpriseToEbitda": 11.906, "52WeekChange": 0.6194539, "SandP52WeekChange": 0.026524067, "lastDividendValue": 1.3, "lastDividendDate": 1658448000, "exchange": "TAI", "quoteType": "EQUITY", "symbol": "1762.TW", "underlyingSymbol": "1762.TW", "shortName": "CHUNGHWA CHEMICAL SYNTHESIS BIO", "longName": "Chunghwa Chemical Synthesis & Biotech Co., Ltd.", "firstTradeDateEpochUtc": 1292806800, "timeZoneFullName": "Asia/Taipei", "timeZoneShortName": "CST", "uuid": "9588a935-52c7-3ccc-8031-67a9162f76cc", "messageBoardId": "finmb_42915199", "gmtOffSetMilliseconds": 28800000, "currentPrice": 93.8, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "totalCash": 300614016, "totalCashPerShare": 3.876, "ebitda": 632580992, "totalDebt": 603262016, "quickRatio": 0.998, "currentRatio": 2.359, "totalRevenue": 2117144064, "debtToEquity": 18.893, "revenuePerShare": 27.297, "returnOnAssets": 0.064780004, "returnOnEquity": 0.15314999, "freeCashflow": 117768624, "operatingCashflow": 733779008, "earningsGrowth": -0.24, "revenueGrowth": 0.069, "grossMargins": 0.45426998, "ebitdaMargins": 0.29879, "operatingMargins": 0.21893999, "financialCurrency": "TWD", "trailingPegRatio": null}